Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by dardanion Sep 12, 2016 6:21pm
152 Views
Post# 25229827

RE:RE:RE:RE:RE:RE:RE:RE:RE:Theralase to Present at Global Investment Conference

RE:RE:RE:RE:RE:RE:RE:RE:RE:Theralase to Present at Global Investment ConferenceThis is what you wrote. You did not say Roger was quoting Health Canada guidelines of which we are all aware has little credibility on this board. Stop trying to spin it to cover up the fact that you made a gross attempt to trick this board into thinking Roger had imparted some special knowledge privately to you that led you to believe next week was a sure bet for ITA approval. You have been caught in the same gross liberties you take with the facts that you practice at will on the HPQ board so just take it like a man and move on. Who by the way are these " others" you refer to, bencro? The fact of the matter is nobody knows, not even I would venture HC themselves when the ITA review process will conclude. One thing is almost certain though. With Roger hinting on the Korelin show that the patient enrollment process could take them until late December, it's very unlikely we'll see any patients get treated until early 2017 and that's what investors are here for not for an ITA that management said they would have by late 2015..

" ITA is imminent. By talking to others and listening carefully when I spoke to Roger I think its the week of Sept 19-23."

Bullboard Posts